Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 546

Related Citations for PubMed (Select 16968127)

1.

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Suguitan AL Jr, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K.

PLoS Med. 2006 Sep;3(9):e360.

2.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.

PMID:
17050041
3.

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.

Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P.

J Virol. 2009 Feb;83(4):1742-53. doi: 10.1128/JVI.01920-08. Epub 2008 Dec 10.

4.

Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets.

Chen Z, Santos C, Aspelund A, Gillim-Ross L, Jin H, Kemble G, Subbarao K.

J Virol. 2009 Jan;83(1):65-72. doi: 10.1128/JVI.01775-08. Epub 2008 Oct 22.

5.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216
6.

Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.

Fan S, Gao Y, Shinya K, Li CK, Li Y, Shi J, Jiang Y, Suo Y, Tong T, Zhong G, Song J, Zhang Y, Tian G, Guan Y, Xu XN, Bu Z, Kawaoka Y, Chen H.

PLoS Pathog. 2009 May;5(5):e1000409. doi: 10.1371/journal.ppat.1000409. Epub 2009 May 1.

7.

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.

Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.

PMID:
19041677
8.

A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.

Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K.

J Virol. 2010 Nov;84(22):11950-60. doi: 10.1128/JVI.01305-10. Epub 2010 Sep 1.

9.

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Aug 6;27(36):4953-60. doi: 10.1016/j.vaccine.2009.05.099. Epub 2009 Jun 21.

PMID:
19540952
10.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
11.

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG.

J Infect Dis. 2006 Jul 15;194(2):159-67. Epub 2006 Jun 9.

12.
13.

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, Brownlee G, Xu X, Lu X, Katz J, Cox N, Matsuoka Y.

Virology. 2003 Jan 5;305(1):192-200.

PMID:
12504552
14.

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

Gambaryan AS, Lomakina NF, Boravleva EY, Kropotkina EA, Mashin VV, Krasilnikov IV, Klimov AI, Rudenko LG.

Influenza Other Respir Viruses. 2012 May;6(3):188-95. doi: 10.1111/j.1750-2659.2011.00291.x. Epub 2011 Sep 23.

PMID:
21951678
15.

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

Chen H, Matsuoka Y, Swayne D, Chen Q, Cox NJ, Murphy BR, Subbarao K.

Vaccine. 2003 Oct 1;21(27-30):4430-6.

PMID:
14505926
16.

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.

Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M.

J Infect Dis. 1999 May;179(5):1132-8.

17.

Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.

Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC.

Vaccine. 2008 May 2;26(19):2307-13. doi: 10.1016/j.vaccine.2008.02.061. Epub 2008 Mar 18.

PMID:
18395947
18.

New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

Steel J.

BioDrugs. 2011 Oct 1;25(5):285-98. doi: 10.2165/11593870-000000000-00000. Review.

PMID:
21942913
19.

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.

Cheng X, Eisenbraun M, Xu Q, Zhou H, Kulkarni D, Subbarao K, Kemble G, Jin H.

PLoS One. 2009;4(2):e4436. doi: 10.1371/journal.pone.0004436. Epub 2009 Feb 11.

20.

Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.

Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, Green B, Shamloul M, Farrance CE, Taggart B, Mytle N, Ugulava N, Rabindran S, Mett V, Chichester JA, Yusibov V.

Vaccine. 2009 Feb 11;27(7):1087-92. doi: 10.1016/j.vaccine.2008.11.108. Epub 2008 Dec 25.

PMID:
19100806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk